Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Editorial

I Ralph Edwards¹, Marie Lindquist¹

¹International Journal of Risk & Safety in Medicine.

The International Journal of Risk & Safety in Medicine

|September 17, 2019

Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Related Concept Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

In the past many in vitro culture systems -- mainly monolayer cultures -- often suffered from the disadvantage that differentiated primary cells had a relatively short life-span and de-differentiated during culture. As a consequence, most of their organ-specific functions were lost rapidly. Thus, in order to reproduce better conditions for these cells in vitro, modifications and adaptations have been made to conventional monolayer...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.

Drug safety·2023

Same author

The International Journal of Risk & Safety in Medicine: Past and future.

The International journal of risk & safety in medicine·2023

Same author

Risk and benefit issues are problems we all face.

The International journal of risk & safety in medicine·2022

Same author

Wiser after the event?

The International journal of risk & safety in medicine·2022

Same author

Future possibilities for The International Journal of Risk and Safety in Medicine.

The International journal of risk & safety in medicine·2021

Same author

What is fake news in science?

The International journal of risk & safety in medicine·2021

Same journal

Drug-induced multisystem syndromes: An overlooked challenge in pharmacovigilance.

The International journal of risk & safety in medicine·2026

Same journal

Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process.

The International journal of risk & safety in medicine·2026

Same journal

Medical science and the madness of crowds; context for our COVID pandemic years.

The International journal of risk & safety in medicine·2026

Same journal

Association between obesity/overweight in adolescents and low food safety knowledge and practice.

The International journal of risk & safety in medicine·2026

Same journal

Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia.

The International journal of risk & safety in medicine·2026

Same journal

Batch-dependent safety signal: Nationwide analysis of suspected adverse events following COVID-19 vaccination in Germany.

The International journal of risk & safety in medicine·2026

See all related articles